{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:11:37Z","timestamp":1785409897117,"version":"3.56.0"},"reference-count":40,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2021.12950","type":"journal-article","created":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T20:12:16Z","timestamp":1627848736000},"source":"Crossref","is-referenced-by-count":6,"title":["Novel bone microenvironment model of castration\u2011resistant prostate cancer with chitosan fiber matrix and osteoblasts"],"prefix":"10.3892","volume":"22","author":[{"given":"Masahiro","family":"Samoto","sequence":"first","affiliation":[{"name":"Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi 755\u20118505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyasu","family":"Matsuyama","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi 755\u20118505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi 755\u20118505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hirata","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi 755\u20118505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Ueno","sequence":"additional","affiliation":[{"name":"Center for Regenerative Medicine, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi 755\u20118505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Ozawa","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi 755\u20118505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi 755\u20118505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi 755\u20118505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Yano","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi 755\u20118505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi 755\u20118505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Haginaka","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, Nishinomiya, Hyogo 663\u20118179, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuyo","family":"Horiyama","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, Nishinomiya, Hyogo 663\u20118179, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Tamada","sequence":"additional","affiliation":[{"name":"Department of Immunology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi 755\u20118505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2021,8,1]]},"reference":[{"key":"key20210907103004_b1-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"key20210907103004_b2-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","article-title":"10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer","volume":"375","author":"Hamdy","year":"2016","journal-title":"N Engl J Med"},{"key":"key20210907103004_b3-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1200\/JCO.2008.17.0563","article-title":"Perioperative activation of disseminated tumor cells in bone marrow of patients with prostate cancer","volume":"27","author":"Weckermann","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20210907103004_b4-ol-0-0-12950","article-title":"SEER Cancer Stat Facts: Prostate Cancer","author":"National Cancer Institute","year":"2020"},{"key":"key20210907103004_b5-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1056\/NEJMoa1503747","article-title":"Chemohormonal therapy in metastatic hormone-sensitive prostate cancer","volume":"373","author":"Sweeney","year":"2015","journal-title":"N Engl J Med"},{"key":"key20210907103004_b6-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"64447","DOI":"10.18632\/oncotarget.10901","article-title":"Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer","volume":"7","author":"Wadosky","year":"2016","journal-title":"Oncotarget"},{"key":"key20210907103004_b7-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"a030635","DOI":"10.1101\/cshperspect.a030635","article-title":"Treatment of advanced prostate cancer-A review of current therapies and future promise","volume":"8","author":"Sumanasuriya","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"key20210907103004_b8-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.eururo.2013.10.055","article-title":"Visceral disease in castration-resistant prostate cancer","volume":"65","author":"Pezaro","year":"2014","journal-title":"Eur Urol"},{"key":"key20210907103004_b9-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/sj.bjc.6606070","article-title":"Enhancement of osteoclastogenic activity in osteolytic prostate cancer cells by physical contact with osteoblasts","volume":"104","author":"Shiirevnyamba","year":"2011","journal-title":"Br J Cancer"},{"key":"key20210907103004_b10-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.actbio.2019.06.012","article-title":"In-air production of 3D co-culture tumor spheroid hydrogels for expedited drug screening","volume":"94","author":"Antunes","year":"2019","journal-title":"Acta Biomater"},{"key":"key20210907103004_b11-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S1470-2045(14)71205-7","article-title":"Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): Final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study","volume":"16","author":"Ryan","year":"2015","journal-title":"Lancet Oncol"},{"key":"key20210907103004_b12-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature17954","article-title":"Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy","volume":"533","author":"Li","year":"2016","journal-title":"Nature"},{"key":"key20210907103004_b13-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1056\/NEJMoa0908127","article-title":"Effect of dutasteride on the risk of prostate cancer","volume":"362","author":"Andriole","year":"2010","journal-title":"N Engl J Med"},{"key":"key20210907103004_b14-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"key20210907103004_b15-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20210907103004_b16-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1200\/JCO.2021.39.6_suppl.112","article-title":"Phase II study of the efficacy of abiraterone acetate with dutasteride for castration resistant prostate cancer","volume":"39","author":"Matsuyama","year":"2021","journal-title":"J Clin Oncol"},{"key":"key20210907103004_b17-ol-0-0-12950","first-page":"1809","article-title":"LNCaP model of human prostatic carcinoma","volume":"43","author":"Horoszewicz","year":"1983","journal-title":"Cancer Res"},{"key":"key20210907103004_b18-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"6503","DOI":"10.1158\/0008-5472.CAN-11-0532","article-title":"Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors","volume":"71","author":"Cai","year":"2011","journal-title":"Cancer Res"},{"key":"key20210907103004_b19-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1002\/jbm.a.36072","article-title":"Long-term liver-specific functions of hepatocytes in electrospun chitosan nanofiber scaffolds coated with fibronectin","volume":"105","author":"Rajendran","year":"2017","journal-title":"J Biomed Mater Res A"},{"key":"key20210907103004_b20-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/bit.24727","article-title":"Functional 3-D cardiac co-culture model using bioactive chitosan nanofiber scaffolds","volume":"110","author":"Hussain","year":"2013","journal-title":"Biotechnol Bioeng"},{"key":"key20210907103004_b21-ol-0-0-12950","first-page":"4293","article-title":"Improving effects of chitosan nanofiber scaffolds on osteoblast proliferation and maturation","volume":"9","author":"Ho","year":"2014","journal-title":"Int J Nanomedicine"},{"key":"key20210907103004_b22-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"44824","DOI":"10.1038\/srep44824","article-title":"Alteration of osteoblast arrangement via direct attack by cancer cells: New insights into bone metastasis","volume":"7","author":"Kimura","year":"2017","journal-title":"Sci Rep"},{"key":"key20210907103004_b23-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1158\/1535-7163.MCT-07-0234","article-title":"Molecular biology of bone metastasis","volume":"6","author":"Kingsley","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"key20210907103004_b24-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1002\/jbmr.2300","article-title":"Prostate cancer cells preferentially home to osteoblast-rich areas in the early stages of bone metastasis: Evidence from in vivo models","volume":"29","author":"Wang","year":"2014","journal-title":"J Bone Miner Res"},{"key":"key20210907103004_b25-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nature12628","article-title":"Selection and adaptation during metastatic cancer progression","volume":"501","author":"Klein","year":"2013","journal-title":"Nature"},{"key":"key20210907103004_b26-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"6213S","DOI":"10.1158\/1078-0432.CCR-06-1007","article-title":"Basic mechanisms responsible for osteolytic and osteoblastic bone metastases","volume":"12","author":"Guise","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20210907103004_b27-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrc3055","article-title":"Cancer to bone: A fatal attraction","volume":"11","author":"Weilbaecher","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"key20210907103004_b28-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4236\/abb.2013.410A4003","article-title":"Role of TGF-\u03b2 in breast cancer bone metastases","volume":"4","author":"Chiechi","year":"2013","journal-title":"Adv Biosci Biotechnol"},{"key":"key20210907103004_b29-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/nrc3603","article-title":"The roles of TGF\u03b2 in the tumour microenvironment","volume":"13","author":"Pickup","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"key20210907103004_b30-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bone.2010.08.004","article-title":"TGF-\u03b2 in cancer and bone: Implications for treatment of bone metastases","volume":"48","author":"Ju\u00e1rez","year":"2011","journal-title":"Bone"},{"key":"key20210907103004_b31-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"35376","DOI":"10.18632\/oncotarget.15686","article-title":"Epithelial-mesenchymal transition in prostate cancer: An overview","volume":"8","author":"Montanari","year":"2017","journal-title":"Oncotarget"},{"key":"key20210907103004_b32-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jsbmb.2016.05.007","article-title":"Epithelial-mesenchymal-transition regulators in prostate cancer: Androgens and beyond","volume":"166","author":"Nakazawa","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"key":"key20210907103004_b33-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1530\/ERC-15-0225","article-title":"Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1\/AR signaling in prostate cancer","volume":"22","author":"Shiota","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"key20210907103004_b34-ol-0-0-12950","first-page":"2587","article-title":"Prostate cancer cells-osteoblast interaction shifts expression of growth\/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts","volume":"9","author":"Fizazi","year":"2003","journal-title":"Clin Cancer Res"},{"key":"key20210907103004_b35-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"120126","DOI":"10.1016\/j.biomaterials.2020.120126","article-title":"3D porous chitosan-chondroitin sulfate scaffolds promote epithelial to mesenchymal transition in prostate cancer cells","volume":"254","author":"Xu","year":"2020","journal-title":"Biomaterials"},{"key":"key20210907103004_b36-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"119311","DOI":"10.1016\/j.biomaterials.2019.119311","article-title":"3D porous chitosan-alginate scaffold stiffness promotes differential responses in prostate cancer cell lines","volume":"217","author":"Xu","year":"2019","journal-title":"Biomaterials"},{"key":"key20210907103004_b37-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.1021\/acs.biomac.5b01032","article-title":"3D porous chitosan-alginate scaffolds as an in vitro model for evaluating nanoparticle-mediated tumor targeting and gene delivery to prostate cancer","volume":"16","author":"Wang","year":"2015","journal-title":"Biomacromolecules"},{"key":"key20210907103004_b38-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3390\/cancers12040777","article-title":"Development of prostate cancer organoid culture models in basic medicine and translational research","volume":"12","author":"Elbadawy","year":"2020","journal-title":"Cancers (Basel)"},{"key":"key20210907103004_b39-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fcell.2016.00074","article-title":"Personalized medicine approaches in prostate cancer employing patient derived 3D organoids and humanized mice","volume":"4","author":"Bartucci","year":"2016","journal-title":"Front Cell Dev Biol"},{"key":"key20210907103004_b40-ol-0-0-12950","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1038\/s41467-018-05366-3","article-title":"A reliable murine model of bone metastasis by injecting cancer cells through caudal arteries","volume":"30","author":"Kuchimaru","year":"2018","journal-title":"Nat Commun"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T07:30:15Z","timestamp":1630999815000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2021.12950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,1]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,8,1]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2021.12950","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,1]]},"article-number":"689"}}